This signing ceremony thrusts the initial research in Malaysia on the treatment of Melasma among Malaysian women.
KAJANG, Selangor, December 14 – 1 Doc Holding Sdn Bhd (One Doc) and Universiti Tunku Abdul Rahman (UTAR) entered into a Memorandum of Agreement (MoA) on 14 December 2020.
The MoA is signed by YAM Tengku Dato’ Seri Baderul Zaman Ibni Almarhum Sultan Mahmud, the Chairman of 1 Doc Holdings Sdn Bhd and Ir. Professor Dr. Ewe Hong Tat, the President and Chief Executive Officer of Universiti Tunku Abdul Rahman. This signing is witnessed by Dr. Terrence Teoh Tean Chun, Director of 1 Doc Holdings Sdn Bhd and Dr. Yong Thian Khok, Director of the Institute of Postgraduate Studies & Research.
The signing of the MoA thrusts a collaborative aesthetic research between the two corporations on the effectiveness and safety evaluation of the beauty grade device One Doc PicopulseTM for the treatment of melasma among Malaysian women. This initial research will be conducted at One Doc centre located at Klang Valley.
“This topic is a new research effort in Malaysia, and we are excited to begin this journey with UTAR in order to help those who are suffering from this skin disorder,” Dr. Terrence Teoh, Executive Director of One Doc remarks.
Melasma is a type of skin pigmentation disorder that causes brown or grey patches to appear on the skin, primarily on the face, especially among pregnant women.
One Doc seeks to develop an improved technique and solution that can overcome melasma with the assistance of the university’s expertise.
The collaborative research has three phases with the initial focus on melasma. The second phase will move its focus to study on possible solutions of anti-hair loss among men. Once conclusive studies are derived from these two phases, it will then initiate the third phase with the focus of product development.
With this collaboration, One Doc also welcomes students who wishes to learn more about aesthetic to intern at their centre.